CYNTHIA TRICKETT: Open Payments
NPI 1538130216 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400,002 in 749 payments from 24 companies in 2025. Trend: 2023 $231,211 · 2024 $394,899 · 2025 $400,002
Speaker / faculty: $229,980Consulting: $81,229Travel & lodging: $69,219Food & beverage: $14,455Honoraria: $3,500Speaker / faculty: $1,503
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 108 | $108,755 |
| Arcutis Biotherapeutics, Inc. | 112 | $61,524 |
| Regeneron Healthcare Solutions, Inc. | 105 | $52,312 |
| UCB, Inc. | 60 | $31,786 |
| Janssen Biotech, Inc. | 46 | $31,357 |
| Lilly USA, LLC | 51 | $28,691 |
| Incyte Corporation | 61 | $22,195 |
| ABBVIE INC. | 34 | $18,362 |
| Amgen Inc. | 37 | $12,269 |
| Organon LLC | 39 | $11,183 |
Products named: DUPIXENT, Zoryve, Bimzelx, TREMFYA, EBGLYSS, Opzelura, SKYRIZI, VTAMA.
Industry payments across TX — which companies pay providers there.
